Observational studyBMC ophthalmology2021

Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab.

Raja Narayanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.